Supplemental Guarantor Information (Details) (USD $) | 3 Months Ended | 9 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | $310.80 | $368.20 | $948.50 | $1,099.20 | ' |
Operating costs and expenses | 253.1 | 302.2 | 824.8 | 887 | ' |
Operating (loss) income | 57.7 | 66 | 123.7 | 212.2 | ' |
Interest expense (income), net | 46.7 | 55.2 | 140 | 163.3 | ' |
Other (income) expense, net | -1.2 | 0.1 | -1.4 | 1.6 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 10.7 | 10.7 | -23 | 47.3 | ' |
Income tax (benefit) expense | 1.4 | 6.8 | 3.6 | 26.3 | ' |
Net income (loss) | 9.3 | 3.9 | -26.6 | 21 | ' |
Total comprehensive income | 34.1 | 6.2 | 9.8 | 27.4 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | 7.8 | ' |
Net income (loss) applicable to common shareowners | 6.7 | 1.3 | -34.4 | 13.2 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 413.7 | 7.7 | 413.7 | 7.7 | ' |
Other current assets | 3.6 | ' | 3.6 | ' | 11.6 |
Total current assets | 650.3 | ' | 650.3 | ' | 303.5 |
Property, plant and equipment, net | 892.5 | ' | 892.5 | ' | 1,587.40 |
Investment in CyrusOne | 480.7 | ' | 480.7 | ' | 0 |
Other noncurrent assets | 44.1 | ' | 44.1 | ' | 86.3 |
Total assets | 2,551.70 | ' | 2,551.70 | ' | 2,872.40 |
Current portion of long-term debt | 508.9 | ' | 508.9 | ' | 13.4 |
Accounts payable | 107.3 | ' | 107.3 | ' | 135.6 |
Other current liabilities | 32.2 | ' | 32.2 | ' | 40.2 |
Total current liabilities | 797.5 | ' | 797.5 | ' | 355.4 |
Long-term debt, less current portion | 2,108.20 | ' | 2,108.20 | ' | 2,676 |
Other noncurrent liabilities | 70.9 | ' | 70.9 | ' | 176.5 |
Total liabilities | 3,238.90 | ' | 3,238.90 | ' | 3,570.60 |
Shareowners' (deficit) equity | -687.2 | ' | -687.2 | ' | -698.2 |
Total liabilities and shareowners' equity (deficit) | 2,551.70 | ' | 2,551.70 | ' | 2,872.40 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 59.8 | 155 | ' |
Capital expenditures | -46.1 | -75.5 | -142 | -242.9 | ' |
Dividends received from CyrusOne | 7.2 | ' | 14.2 | 0 | ' |
Proceeds from sale of assets | ' | ' | 1.8 | 0.6 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | -12.2 | 0 | ' |
Cash flows used in investing activities | ' | ' | -137.8 | -252.7 | ' |
Issuance of long-term debt | ' | ' | 536 | 0 | ' |
Debt issuance costs | ' | ' | -6.4 | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | -52 | 44 | ' |
Repayment of debt | ' | ' | -6.7 | -11.3 | ' |
Common stock repurchase | ' | ' | 0 | -0.3 | ' |
Proceeds from exercise of options and warrants | ' | ' | 6.8 | 8.1 | ' |
Other financing activities | ' | ' | -2.3 | -1 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 468.1 | 31.7 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | 390.1 | -66 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 23.6 | 73.7 | ' |
Cash and cash equivalents at end of period | 413.7 | 7.7 | 413.7 | 7.7 | ' |
Notes guaranteed by subsidiaries [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | 310.8 | 368.2 | 948.5 | 1,099.20 | ' |
Operating costs and expenses | 253.1 | 302.2 | 824.8 | 887 | ' |
Operating (loss) income | 57.7 | 66 | 123.7 | 212.2 | ' |
Interest expense (income), net | 46.7 | 55.2 | 140 | 163.3 | ' |
Other (income) expense, net | 0.3 | 0.1 | 6.7 | 1.6 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 10.7 | 10.7 | -23 | 47.3 | ' |
Income tax (benefit) expense | 1.4 | 6.8 | 3.6 | 26.3 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 9.3 | 3.9 | -26.6 | 21 | ' |
Other comprehensive income (loss) | 24.8 | 2.3 | 36.4 | 6.4 | ' |
Total comprehensive income | 34.1 | 6.2 | 9.8 | 27.4 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | 7.8 | ' |
Net income (loss) applicable to common shareowners | 6.7 | 1.3 | -34.4 | 13.2 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 413.7 | 7.7 | 413.7 | 7.7 | ' |
Receivables, net | 161.4 | ' | 161.4 | ' | 199 |
Other current assets | 75.2 | ' | 75.2 | ' | 80.9 |
Total current assets | 650.3 | ' | 650.3 | ' | 303.5 |
Property, plant and equipment, net | 892.5 | ' | 892.5 | ' | 1,587.40 |
Investment in CyrusOne | 480.7 | ' | 480.7 | ' | ' |
Goodwill and intangibles, net | 107.2 | ' | 107.2 | ' | 487.4 |
Investments in and advances to subsidiaries | 0 | ' | 0 | ' | 0 |
Other noncurrent assets | 421 | ' | 421 | ' | 494.1 |
Total assets | 2,551.70 | ' | 2,551.70 | ' | 2,872.40 |
Current portion of long-term debt | 508.9 | ' | 508.9 | ' | 13.4 |
Accounts payable | 108.3 | ' | 108.3 | ' | 135.6 |
Other current liabilities | 180.3 | ' | 180.3 | ' | 206.4 |
Total current liabilities | 797.5 | ' | 797.5 | ' | 355.4 |
Long-term debt, less current portion | 2,108.20 | ' | 2,108.20 | ' | 2,676 |
Other noncurrent liabilities | 333.2 | ' | 333.2 | ' | 539.2 |
Intercompany payables | 0 | ' | 0 | ' | 0 |
Total liabilities | 3,238.90 | ' | 3,238.90 | ' | 3,570.60 |
Shareowners' (deficit) equity | -687.2 | ' | -687.2 | ' | -698.2 |
Total liabilities and shareowners' equity (deficit) | 2,551.70 | ' | 2,551.70 | ' | 2,872.40 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 59.8 | 155 | ' |
Capital expenditures | ' | ' | -142 | -242.9 | ' |
Dividends received from CyrusOne | ' | ' | 14.2 | ' | ' |
Proceeds from sale of assets | ' | ' | 1.8 | 0.6 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | -12.2 | ' | ' |
Other investing activities | ' | ' | 0.4 | -10.4 | ' |
Cash flows used in investing activities | ' | ' | -137.8 | -252.7 | ' |
Issuance of long-term debt | ' | ' | 536 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | 0 | ' |
Debt issuance costs | ' | ' | -6.4 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | -52 | 44 | ' |
Repayment of debt | ' | ' | -6.7 | -11.3 | ' |
Common stock repurchase | ' | ' | ' | -0.3 | ' |
Proceeds from exercise of options and warrants | ' | ' | 6.8 | 8.1 | ' |
Other financing activities | ' | ' | -9.6 | -8.8 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 468.1 | 31.7 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | 390.1 | -66 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 23.6 | 73.7 | ' |
Cash and cash equivalents at end of period | 413.7 | 7.7 | 413.7 | 7.7 | ' |
Notes guaranteed by subsidiaries [Member] | Parent Company [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | 0 | 0 | 0 | 0 | ' |
Operating costs and expenses | 1.5 | 12.5 | 51.2 | 23.6 | ' |
Operating (loss) income | -1.5 | -12.5 | -51.2 | -23.6 | ' |
Interest expense (income), net | 42.9 | 41.1 | 125 | 122.5 | ' |
Other (income) expense, net | -0.4 | -0.5 | -1.1 | -1.2 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | -44 | -53.1 | -175.1 | -144.9 | ' |
Income tax (benefit) expense | -18.5 | -16.1 | -59.8 | -45.9 | ' |
Equity in earnings of subsidiaries, net of tax | 34.8 | 40.9 | 88.7 | 120 | ' |
Net income (loss) | 9.3 | 3.9 | -26.6 | 21 | ' |
Other comprehensive income (loss) | 24.8 | 2.2 | 36.5 | 6.3 | ' |
Total comprehensive income | 34.1 | 6.1 | 9.9 | 27.3 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | 7.8 | ' |
Net income (loss) applicable to common shareowners | 6.7 | 1.3 | -34.4 | 13.2 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 411.1 | 2.3 | 411.1 | 2.3 | ' |
Receivables, net | 1.6 | ' | 1.6 | ' | 1 |
Other current assets | 2.6 | ' | 2.6 | ' | 3.1 |
Total current assets | 415.3 | ' | 415.3 | ' | 7.9 |
Property, plant and equipment, net | 0.1 | ' | 0.1 | ' | 0.1 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' |
Goodwill and intangibles, net | 0 | ' | 0 | ' | 0 |
Investments in and advances to subsidiaries | 1,546.80 | ' | 1,546.80 | ' | 1,449.90 |
Other noncurrent assets | 380.6 | ' | 380.6 | ' | 384.6 |
Total assets | 2,342.80 | ' | 2,342.80 | ' | 1,842.50 |
Current portion of long-term debt | 501.7 | ' | 501.7 | ' | 0 |
Accounts payable | 1 | ' | 1 | ' | 1.2 |
Other current liabilities | 93.3 | ' | 93.3 | ' | 85.6 |
Total current liabilities | 596 | ' | 596 | ' | 86.8 |
Long-term debt, less current portion | 1,877.20 | ' | 1,877.20 | ' | 1,841.70 |
Other noncurrent liabilities | 274.3 | ' | 274.3 | ' | 383.3 |
Intercompany payables | 282.5 | ' | 282.5 | ' | 228.9 |
Total liabilities | 3,030 | ' | 3,030 | ' | 2,540.70 |
Shareowners' (deficit) equity | -687.2 | ' | -687.2 | ' | -698.2 |
Total liabilities and shareowners' equity (deficit) | 2,342.80 | ' | 2,342.80 | ' | 1,842.50 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -165 | -69.1 | ' |
Capital expenditures | ' | ' | 0 | 0 | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | ' |
Proceeds from sale of assets | ' | ' | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | 0 | ' | ' |
Other investing activities | ' | ' | 0 | 0 | ' |
Cash flows used in investing activities | ' | ' | 0 | 0 | ' |
Issuance of long-term debt | ' | ' | 536 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | 45.5 | 2.9 | ' |
Debt issuance costs | ' | ' | -6.4 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | 0 | 0 | ' |
Common stock repurchase | ' | ' | ' | -0.3 | ' |
Proceeds from exercise of options and warrants | ' | ' | 6.8 | 8.1 | ' |
Other financing activities | ' | ' | -9.6 | -8.9 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 572.3 | 1.8 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | 407.3 | -67.3 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 3.8 | 69.6 | ' |
Cash and cash equivalents at end of period | 411.1 | 2.3 | 411.1 | 2.3 | ' |
Notes guaranteed by subsidiaries [Member] | Guarantor Subsidiaries [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | 177.4 | 176.6 | 530.7 | 530.5 | ' |
Operating costs and expenses | 162.5 | 158 | 496.1 | 474.8 | ' |
Operating (loss) income | 14.9 | 18.6 | 34.6 | 55.7 | ' |
Interest expense (income), net | 3.5 | 1.8 | 11.2 | 5.6 | ' |
Other (income) expense, net | 3.2 | 2.3 | 12.1 | 6.4 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 8.2 | 14.5 | 11.3 | 43.7 | ' |
Income tax (benefit) expense | 3.1 | 4.6 | 11.9 | 16.2 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 3.5 | 0.7 | -10.3 | ' |
Net income (loss) | 5.1 | 13.4 | 0.1 | 17.2 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | 0 | ' |
Total comprehensive income | 5.1 | 13.4 | 0.1 | 17.2 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 5.1 | 13.4 | 0.1 | 17.2 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0.5 | 0.7 | 0.5 | 0.7 | ' |
Receivables, net | 7.2 | ' | 7.2 | ' | 1.2 |
Other current assets | 39.9 | ' | 39.9 | ' | 27.7 |
Total current assets | 47.6 | ' | 47.6 | ' | 29.2 |
Property, plant and equipment, net | 196 | ' | 196 | ' | 220.9 |
Investment in CyrusOne | 480.7 | ' | 480.7 | ' | ' |
Goodwill and intangibles, net | 104.9 | ' | 104.9 | ' | 106.4 |
Investments in and advances to subsidiaries | 340.3 | ' | 340.3 | ' | 506.4 |
Other noncurrent assets | 190.6 | ' | 190.6 | ' | 218.5 |
Total assets | 1,360.10 | ' | 1,360.10 | ' | 1,081.40 |
Current portion of long-term debt | 3 | ' | 3 | ' | 3.9 |
Accounts payable | 72.4 | ' | 72.4 | ' | 90.2 |
Other current liabilities | 38.1 | ' | 38.1 | ' | 33.6 |
Total current liabilities | 113.5 | ' | 113.5 | ' | 127.7 |
Long-term debt, less current portion | 87.2 | ' | 87.2 | ' | 88.4 |
Other noncurrent liabilities | 62.2 | ' | 62.2 | ' | 90.6 |
Intercompany payables | 144.7 | ' | 144.7 | ' | 160 |
Total liabilities | 407.6 | ' | 407.6 | ' | 466.7 |
Shareowners' (deficit) equity | 952.5 | ' | 952.5 | ' | 614.7 |
Total liabilities and shareowners' equity (deficit) | 1,360.10 | ' | 1,360.10 | ' | 1,081.40 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 27.4 | 47.1 | ' |
Capital expenditures | ' | ' | -25.6 | -22.9 | ' |
Dividends received from CyrusOne | ' | ' | 14.2 | ' | ' |
Proceeds from sale of assets | ' | ' | 0 | 0.2 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | 0 | ' | ' |
Other investing activities | ' | ' | 0 | 0 | ' |
Cash flows used in investing activities | ' | ' | -11.4 | -22.7 | ' |
Issuance of long-term debt | ' | ' | 0 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | -12.6 | -21 | ' |
Debt issuance costs | ' | ' | 0 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | -3.2 | -3.5 | ' |
Common stock repurchase | ' | ' | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0.1 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -15.8 | -24.4 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | 0.2 | 0 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0.3 | 0.7 | ' |
Cash and cash equivalents at end of period | 0.5 | 0.7 | 0.5 | 0.7 | ' |
Notes guaranteed by subsidiaries [Member] | Non-Guarantor Subsidiaries [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | 147.5 | 207 | 460 | 615.1 | ' |
Operating costs and expenses | 103.2 | 147.1 | 319.7 | 435 | ' |
Operating (loss) income | 44.3 | 59.9 | 140.3 | 180.1 | ' |
Interest expense (income), net | 0.3 | 12.3 | 3.8 | 35.2 | ' |
Other (income) expense, net | -2.5 | -1.7 | -4.3 | -3.6 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 46.5 | 49.3 | 140.8 | 148.5 | ' |
Income tax (benefit) expense | 16.8 | 18.3 | 51.5 | 56 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 29.7 | 31 | 89.3 | 92.5 | ' |
Other comprehensive income (loss) | 0 | 0.1 | -0.1 | 0.1 | ' |
Total comprehensive income | 29.7 | 31.1 | 89.2 | 92.6 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 29.7 | 31 | 89.3 | 92.5 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 2.1 | 4.7 | 2.1 | 4.7 | ' |
Receivables, net | 152.6 | ' | 152.6 | ' | 196.8 |
Other current assets | 33.1 | ' | 33.1 | ' | 50.5 |
Total current assets | 187.8 | ' | 187.8 | ' | 266.8 |
Property, plant and equipment, net | 696.4 | ' | 696.4 | ' | 1,366.40 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' |
Goodwill and intangibles, net | 2.3 | ' | 2.3 | ' | 381 |
Investments in and advances to subsidiaries | 260.7 | ' | 260.7 | ' | 192.5 |
Other noncurrent assets | 5.1 | ' | 5.1 | ' | 54.1 |
Total assets | 1,152.30 | ' | 1,152.30 | ' | 2,260.80 |
Current portion of long-term debt | 4.2 | ' | 4.2 | ' | 9.5 |
Accounts payable | 34.9 | ' | 34.9 | ' | 44.2 |
Other current liabilities | 49.5 | ' | 49.5 | ' | 86.3 |
Total current liabilities | 88.6 | ' | 88.6 | ' | 140 |
Long-term debt, less current portion | 143.8 | ' | 143.8 | ' | 745.9 |
Other noncurrent liabilities | 151.8 | ' | 151.8 | ' | 229.7 |
Intercompany payables | 133.7 | ' | 133.7 | ' | 102.6 |
Total liabilities | 517.9 | ' | 517.9 | ' | 1,218.20 |
Shareowners' (deficit) equity | 634.4 | ' | 634.4 | ' | 1,042.60 |
Total liabilities and shareowners' equity (deficit) | 1,152.30 | ' | 1,152.30 | ' | 2,260.80 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 197.4 | 177 | ' |
Capital expenditures | ' | ' | -116.4 | -220 | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | ' |
Proceeds from sale of assets | ' | ' | 1.8 | 0.4 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | -12.2 | ' | ' |
Other investing activities | ' | ' | 0.4 | -10.4 | ' |
Cash flows used in investing activities | ' | ' | -126.4 | -230 | ' |
Issuance of long-term debt | ' | ' | 0 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | -32.9 | 18.1 | ' |
Debt issuance costs | ' | ' | 0 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | -52 | 44 | ' |
Repayment of debt | ' | ' | -3.5 | -7.8 | ' |
Common stock repurchase | ' | ' | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -88.4 | 54.3 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | -17.4 | 1.3 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 19.5 | 3.4 | ' |
Cash and cash equivalents at end of period | 2.1 | 4.7 | 2.1 | 4.7 | ' |
Notes guaranteed by subsidiaries [Member] | Consolidation, Eliminations [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | -14.1 | -15.4 | -42.2 | -46.4 | ' |
Operating costs and expenses | -14.1 | -15.4 | -42.2 | -46.4 | ' |
Operating (loss) income | 0 | 0 | 0 | 0 | ' |
Interest expense (income), net | 0 | 0 | 0 | 0 | ' |
Other (income) expense, net | 0 | 0 | 0 | 0 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 0 | 0 | 0 | 0 | ' |
Income tax (benefit) expense | 0 | 0 | 0 | 0 | ' |
Equity in earnings of subsidiaries, net of tax | -34.8 | -44.4 | -89.4 | -109.7 | ' |
Net income (loss) | -34.8 | -44.4 | -89.4 | -109.7 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | 0 | ' |
Total comprehensive income | -34.8 | -44.4 | -89.4 | -109.7 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | -34.8 | -44.4 | -89.4 | -109.7 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0 | 0 | 0 | 0 | ' |
Receivables, net | 0 | ' | 0 | ' | 0 |
Other current assets | -0.4 | ' | -0.4 | ' | -0.4 |
Total current assets | -0.4 | ' | -0.4 | ' | -0.4 |
Property, plant and equipment, net | 0 | ' | 0 | ' | 0 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' |
Goodwill and intangibles, net | 0 | ' | 0 | ' | 0 |
Investments in and advances to subsidiaries | -2,147.80 | ' | -2,147.80 | ' | -2,148.80 |
Other noncurrent assets | -155.3 | ' | -155.3 | ' | -163.1 |
Total assets | -2,303.50 | ' | -2,303.50 | ' | -2,312.30 |
Current portion of long-term debt | 0 | ' | 0 | ' | 0 |
Accounts payable | 0 | ' | 0 | ' | 0 |
Other current liabilities | -0.6 | ' | -0.6 | ' | 0.9 |
Total current liabilities | -0.6 | ' | -0.6 | ' | 0.9 |
Long-term debt, less current portion | 0 | ' | 0 | ' | 0 |
Other noncurrent liabilities | -155.1 | ' | -155.1 | ' | -164.4 |
Intercompany payables | -560.9 | ' | -560.9 | ' | -491.5 |
Total liabilities | -716.6 | ' | -716.6 | ' | -655 |
Shareowners' (deficit) equity | -1,586.90 | ' | -1,586.90 | ' | -1,657.30 |
Total liabilities and shareowners' equity (deficit) | -2,303.50 | ' | -2,303.50 | ' | -2,312.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 0 | 0 | ' |
Capital expenditures | ' | ' | 0 | 0 | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | ' |
Proceeds from sale of assets | ' | ' | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | 0 | ' | ' |
Other investing activities | ' | ' | 0 | 0 | ' |
Cash flows used in investing activities | ' | ' | 0 | 0 | ' |
Issuance of long-term debt | ' | ' | 0 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | 0 | ' |
Debt issuance costs | ' | ' | 0 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | 0 | 0 | ' |
Common stock repurchase | ' | ' | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 0 | 0 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | 0 | 0 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0 | 0 | ' |
Cash and cash equivalents at end of period | 0 | 0 | 0 | 0 | ' |
Notes guaranteed by parent [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | 310.8 | 368.2 | 948.5 | 1,099.20 | ' |
Operating costs and expenses | 253.1 | 302.2 | 824.8 | 887 | ' |
Operating (loss) income | 57.7 | 66 | 123.7 | 212.2 | ' |
Interest expense (income), net | 46.7 | 55.2 | 140 | 163.3 | ' |
Other (income) expense, net | 0.3 | 0.1 | 6.7 | 1.6 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 10.7 | 10.7 | -23 | 47.3 | ' |
Income tax (benefit) expense | 1.4 | 6.8 | 3.6 | 26.3 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 9.3 | 3.9 | -26.6 | 21 | ' |
Other comprehensive income (loss) | 24.8 | 2.3 | 36.4 | 6.4 | ' |
Total comprehensive income | 34.1 | 6.2 | 9.8 | 27.4 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | 7.8 | ' |
Net income (loss) applicable to common shareowners | 6.7 | 1.3 | -34.4 | 13.2 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 413.7 | 7.7 | 413.7 | 7.7 | ' |
Receivables, net | 161.4 | ' | 161.4 | ' | 199 |
Other current assets | 75.2 | ' | 75.2 | ' | 80.9 |
Total current assets | 650.3 | ' | 650.3 | ' | 303.5 |
Property, plant and equipment, net | 892.5 | ' | 892.5 | ' | 1,587.40 |
Investment in CyrusOne | 480.7 | ' | 480.7 | ' | ' |
Goodwill and intangibles, net | 107.2 | ' | 107.2 | ' | 487.4 |
Investments in and advances to subsidiaries | 0 | ' | 0 | ' | 0 |
Other noncurrent assets | 421 | ' | 421 | ' | 494.1 |
Total assets | 2,551.70 | ' | 2,551.70 | ' | 2,872.40 |
Current portion of long-term debt | 508.9 | ' | 508.9 | ' | 13.4 |
Accounts payable | 108.3 | ' | 108.3 | ' | 135.6 |
Other current liabilities | 180.3 | ' | 180.3 | ' | 206.4 |
Total current liabilities | 797.5 | ' | 797.5 | ' | 355.4 |
Long-term debt, less current portion | 2,108.20 | ' | 2,108.20 | ' | 2,676 |
Other noncurrent liabilities | 333.2 | ' | 333.2 | ' | 539.2 |
Intercompany payables | 0 | ' | 0 | ' | 0 |
Total liabilities | 3,238.90 | ' | 3,238.90 | ' | 3,570.60 |
Shareowners' (deficit) equity | -687.2 | ' | -687.2 | ' | -698.2 |
Total liabilities and shareowners' equity (deficit) | 2,551.70 | ' | 2,551.70 | ' | 2,872.40 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 59.8 | 155 | ' |
Capital expenditures | ' | ' | -142 | -242.9 | ' |
Dividends received from CyrusOne | ' | ' | 14.2 | ' | ' |
Proceeds from sale of assets | ' | ' | 1.8 | 0.6 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | -12.2 | ' | ' |
Other investing activities | ' | ' | 0.4 | -10.4 | ' |
Cash flows used in investing activities | ' | ' | -137.8 | -252.7 | ' |
Issuance of long-term debt | ' | ' | 536 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | 0 | ' |
Debt issuance costs | ' | ' | -6.4 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | -52 | 44 | ' |
Repayment of debt | ' | ' | -6.7 | -11.3 | ' |
Common stock repurchase | ' | ' | ' | -0.3 | ' |
Proceeds from exercise of options and warrants | ' | ' | 6.8 | 8.1 | ' |
Other financing activities | ' | ' | -9.6 | -8.8 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 468.1 | 31.7 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | 390.1 | -66 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 23.6 | 73.7 | ' |
Cash and cash equivalents at end of period | 413.7 | 7.7 | 413.7 | 7.7 | ' |
Notes guaranteed by parent [Member] | Parent Company [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | 0 | 0 | 0 | 0 | ' |
Operating costs and expenses | 1.5 | 12.5 | 51.2 | 23.6 | ' |
Operating (loss) income | -1.5 | -12.5 | -51.2 | -23.6 | ' |
Interest expense (income), net | 42.9 | 41.1 | 125 | 122.5 | ' |
Other (income) expense, net | -0.4 | -0.5 | -1.1 | -1.2 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | -44 | -53.1 | -175.1 | -144.9 | ' |
Income tax (benefit) expense | -18.5 | -16.1 | -59.8 | -45.9 | ' |
Equity in earnings of subsidiaries, net of tax | 34.8 | 40.9 | 88.7 | 120 | ' |
Net income (loss) | 9.3 | 3.9 | -26.6 | 21 | ' |
Other comprehensive income (loss) | 24.8 | 2.2 | 36.5 | 6.3 | ' |
Total comprehensive income | 34.1 | 6.1 | 9.9 | 27.3 | ' |
Preferred stock dividends | 2.6 | 2.6 | 7.8 | 7.8 | ' |
Net income (loss) applicable to common shareowners | 6.7 | 1.3 | -34.4 | 13.2 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 411.1 | 2.3 | 411.1 | 2.3 | ' |
Receivables, net | 1.6 | ' | 1.6 | ' | 1 |
Other current assets | 2.6 | ' | 2.6 | ' | 3.1 |
Total current assets | 415.3 | ' | 415.3 | ' | 7.9 |
Property, plant and equipment, net | 0.1 | ' | 0.1 | ' | 0.1 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' |
Goodwill and intangibles, net | 0 | ' | 0 | ' | 0 |
Investments in and advances to subsidiaries | 1,546.80 | ' | 1,546.80 | ' | 1,449.90 |
Other noncurrent assets | 380.6 | ' | 380.6 | ' | 384.6 |
Total assets | 2,342.80 | ' | 2,342.80 | ' | 1,842.50 |
Current portion of long-term debt | 501.7 | ' | 501.7 | ' | 0 |
Accounts payable | 1 | ' | 1 | ' | 1.2 |
Other current liabilities | 93.3 | ' | 93.3 | ' | 85.6 |
Total current liabilities | 596 | ' | 596 | ' | 86.8 |
Long-term debt, less current portion | 1,877.20 | ' | 1,877.20 | ' | 1,841.70 |
Other noncurrent liabilities | 274.3 | ' | 274.3 | ' | 383.3 |
Intercompany payables | 282.5 | ' | 282.5 | ' | 228.9 |
Total liabilities | 3,030 | ' | 3,030 | ' | 2,540.70 |
Shareowners' (deficit) equity | -687.2 | ' | -687.2 | ' | -698.2 |
Total liabilities and shareowners' equity (deficit) | 2,342.80 | ' | 2,342.80 | ' | 1,842.50 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -165 | -69.1 | ' |
Capital expenditures | ' | ' | 0 | 0 | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | ' |
Proceeds from sale of assets | ' | ' | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | 0 | ' | ' |
Other investing activities | ' | ' | 0 | 0 | ' |
Cash flows used in investing activities | ' | ' | 0 | 0 | ' |
Issuance of long-term debt | ' | ' | 536 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | 45.5 | 2.9 | ' |
Debt issuance costs | ' | ' | -6.4 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | 0 | 0 | ' |
Common stock repurchase | ' | ' | ' | -0.3 | ' |
Proceeds from exercise of options and warrants | ' | ' | 6.8 | 8.1 | ' |
Other financing activities | ' | ' | -9.6 | -8.9 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 572.3 | 1.8 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | 407.3 | -67.3 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 3.8 | 69.6 | ' |
Cash and cash equivalents at end of period | 411.1 | 2.3 | 411.1 | 2.3 | ' |
Notes guaranteed by parent [Member] | Cincinnati Bell Telephone Company [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | 161.4 | 160.8 | 482.3 | 482 | ' |
Operating costs and expenses | 115.3 | 112 | 340 | 324.8 | ' |
Operating (loss) income | 46.1 | 48.8 | 142.3 | 157.2 | ' |
Interest expense (income), net | -0.3 | -0.6 | -1.4 | -0.8 | ' |
Other (income) expense, net | 1.8 | 0.6 | 4.4 | 2.9 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 44.6 | 48.8 | 139.3 | 155.1 | ' |
Income tax (benefit) expense | 16.4 | 18.1 | 51.2 | 56.6 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 28.2 | 30.7 | 88.1 | 98.5 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | 0 | ' |
Total comprehensive income | 28.2 | 30.7 | 88.1 | 98.5 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 28.2 | 30.7 | 88.1 | 98.5 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 2 | 1.3 | 2 | 1.3 | ' |
Receivables, net | 0 | ' | 0 | ' | 0 |
Other current assets | 29.3 | ' | 29.3 | ' | 34.4 |
Total current assets | 31.3 | ' | 31.3 | ' | 36.3 |
Property, plant and equipment, net | 694.2 | ' | 694.2 | ' | 646.7 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' |
Goodwill and intangibles, net | 2.3 | ' | 2.3 | ' | 2.3 |
Investments in and advances to subsidiaries | 288.8 | ' | 288.8 | ' | 228.2 |
Other noncurrent assets | 6.2 | ' | 6.2 | ' | 6.3 |
Total assets | 1,022.80 | ' | 1,022.80 | ' | 919.8 |
Current portion of long-term debt | 3.9 | ' | 3.9 | ' | 3 |
Accounts payable | 58.7 | ' | 58.7 | ' | 61.7 |
Other current liabilities | 50.8 | ' | 50.8 | ' | 50.2 |
Total current liabilities | 113.4 | ' | 113.4 | ' | 114.9 |
Long-term debt, less current portion | 142.3 | ' | 142.3 | ' | 141.3 |
Other noncurrent liabilities | 153.9 | ' | 153.9 | ' | 138.6 |
Intercompany payables | 0 | ' | 0 | ' | 0 |
Total liabilities | 409.6 | ' | 409.6 | ' | 394.8 |
Shareowners' (deficit) equity | 613.2 | ' | 613.2 | ' | 525 |
Total liabilities and shareowners' equity (deficit) | 1,022.80 | ' | 1,022.80 | ' | 919.8 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 170.1 | 169.7 | ' |
Capital expenditures | ' | ' | -108.7 | -73.6 | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | ' |
Proceeds from sale of assets | ' | ' | 1.8 | 0.4 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | 0 | ' | ' |
Other investing activities | ' | ' | 0 | 0 | ' |
Cash flows used in investing activities | ' | ' | -106.9 | -73.2 | ' |
Issuance of long-term debt | ' | ' | 0 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | -60.5 | -94.3 | ' |
Debt issuance costs | ' | ' | 0 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | -2.6 | -2.3 | ' |
Common stock repurchase | ' | ' | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -63.1 | -96.6 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | 0.1 | -0.1 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 1.9 | 1.4 | ' |
Cash and cash equivalents at end of period | 2 | 1.3 | 2 | 1.3 | ' |
Notes guaranteed by parent [Member] | Non-Guarantor Subsidiaries [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | 163.5 | 222.8 | 508.4 | 663.6 | ' |
Operating costs and expenses | 150.4 | 193.1 | 475.8 | 585 | ' |
Operating (loss) income | 13.1 | 29.7 | 32.6 | 78.6 | ' |
Interest expense (income), net | 4.1 | 14.7 | 16.4 | 41.6 | ' |
Other (income) expense, net | -1.1 | 0 | 3.4 | -0.1 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 10.1 | 15 | 12.8 | 37.1 | ' |
Income tax (benefit) expense | 3.5 | 4.8 | 12.2 | 15.6 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 6.6 | 10.2 | 0.6 | 21.5 | ' |
Other comprehensive income (loss) | 0 | 0.1 | -0.1 | 0.1 | ' |
Total comprehensive income | 6.6 | 10.3 | 0.5 | 21.6 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 6.6 | 10.2 | 0.6 | 21.5 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0.6 | 4.1 | 0.6 | 4.1 | ' |
Receivables, net | 159.8 | ' | 159.8 | ' | 198 |
Other current assets | 43.7 | ' | 43.7 | ' | 43.8 |
Total current assets | 204.1 | ' | 204.1 | ' | 259.7 |
Property, plant and equipment, net | 198.2 | ' | 198.2 | ' | 940.6 |
Investment in CyrusOne | 480.7 | ' | 480.7 | ' | ' |
Goodwill and intangibles, net | 104.9 | ' | 104.9 | ' | 485.1 |
Investments in and advances to subsidiaries | 0 | ' | 0 | ' | 0 |
Other noncurrent assets | 189.5 | ' | 189.5 | ' | 266.3 |
Total assets | 1,177.40 | ' | 1,177.40 | ' | 1,951.70 |
Current portion of long-term debt | 3.3 | ' | 3.3 | ' | 10.4 |
Accounts payable | 48.6 | ' | 48.6 | ' | 72.7 |
Other current liabilities | 36.8 | ' | 36.8 | ' | 69.7 |
Total current liabilities | 88.7 | ' | 88.7 | ' | 152.8 |
Long-term debt, less current portion | 88.7 | ' | 88.7 | ' | 693 |
Other noncurrent liabilities | 60.1 | ' | 60.1 | ' | 181.7 |
Intercompany payables | 292.7 | ' | 292.7 | ' | 276.4 |
Total liabilities | 530.2 | ' | 530.2 | ' | 1,303.90 |
Shareowners' (deficit) equity | 647.2 | ' | 647.2 | ' | 647.8 |
Total liabilities and shareowners' equity (deficit) | 1,177.40 | ' | 1,177.40 | ' | 1,951.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 54.7 | 54.4 | ' |
Capital expenditures | ' | ' | -33.3 | -169.3 | ' |
Dividends received from CyrusOne | ' | ' | 14.2 | ' | ' |
Proceeds from sale of assets | ' | ' | 0 | 0.2 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | -12.2 | ' | ' |
Other investing activities | ' | ' | 0.4 | -10.4 | ' |
Cash flows used in investing activities | ' | ' | -30.9 | -179.5 | ' |
Issuance of long-term debt | ' | ' | 0 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | 15 | 91.4 | ' |
Debt issuance costs | ' | ' | 0 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | -52 | 44 | ' |
Repayment of debt | ' | ' | -4.1 | -9 | ' |
Common stock repurchase | ' | ' | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0.1 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -41.1 | 126.5 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | -17.3 | 1.4 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 17.9 | 2.7 | ' |
Cash and cash equivalents at end of period | 0.6 | 4.1 | 0.6 | 4.1 | ' |
Notes guaranteed by parent [Member] | Consolidation, Eliminations [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income | ' | ' | ' | ' | ' |
Revenue | -14.1 | -15.4 | -42.2 | -46.4 | ' |
Operating costs and expenses | -14.1 | -15.4 | -42.2 | -46.4 | ' |
Operating (loss) income | 0 | 0 | 0 | 0 | ' |
Interest expense (income), net | 0 | 0 | 0 | 0 | ' |
Other (income) expense, net | 0 | 0 | 0 | 0 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 0 | 0 | 0 | 0 | ' |
Income tax (benefit) expense | 0 | 0 | 0 | 0 | ' |
Equity in earnings of subsidiaries, net of tax | -34.8 | -40.9 | -88.7 | -120 | ' |
Net income (loss) | -34.8 | -40.9 | -88.7 | -120 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | 0 | ' |
Total comprehensive income | -34.8 | -40.9 | -88.7 | -120 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | -34.8 | -40.9 | -88.7 | -120 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0 | 0 | 0 | 0 | ' |
Receivables, net | 0 | ' | 0 | ' | 0 |
Other current assets | -0.4 | ' | -0.4 | ' | -0.4 |
Total current assets | -0.4 | ' | -0.4 | ' | -0.4 |
Property, plant and equipment, net | 0 | ' | 0 | ' | 0 |
Investment in CyrusOne | 0 | ' | 0 | ' | ' |
Goodwill and intangibles, net | 0 | ' | 0 | ' | 0 |
Investments in and advances to subsidiaries | -1,835.60 | ' | -1,835.60 | ' | -1,678.10 |
Other noncurrent assets | -155.3 | ' | -155.3 | ' | -163.1 |
Total assets | -1,991.30 | ' | -1,991.30 | ' | -1,841.60 |
Current portion of long-term debt | 0 | ' | 0 | ' | 0 |
Accounts payable | 0 | ' | 0 | ' | 0 |
Other current liabilities | -0.6 | ' | -0.6 | ' | 0.9 |
Total current liabilities | -0.6 | ' | -0.6 | ' | 0.9 |
Long-term debt, less current portion | 0 | ' | 0 | ' | 0 |
Other noncurrent liabilities | -155.1 | ' | -155.1 | ' | -164.4 |
Intercompany payables | -575.2 | ' | -575.2 | ' | -505.3 |
Total liabilities | -730.9 | ' | -730.9 | ' | -668.8 |
Shareowners' (deficit) equity | -1,260.40 | ' | -1,260.40 | ' | -1,172.80 |
Total liabilities and shareowners' equity (deficit) | -1,991.30 | ' | -1,991.30 | ' | -1,841.60 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 0 | 0 | ' |
Capital expenditures | ' | ' | 0 | 0 | ' |
Dividends received from CyrusOne | ' | ' | 0 | ' | ' |
Proceeds from sale of assets | ' | ' | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | 0 | ' | ' |
Other investing activities | ' | ' | 0 | 0 | ' |
Cash flows used in investing activities | ' | ' | 0 | 0 | ' |
Issuance of long-term debt | ' | ' | 0 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | 0 | ' |
Debt issuance costs | ' | ' | 0 | ' | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | 0 | 0 | ' |
Common stock repurchase | ' | ' | ' | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 0 | 0 | ' |
Increase (decrease) in cash and cash equivalents | ' | ' | 0 | 0 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0 | 0 | ' |
Cash and cash equivalents at end of period | 0 | 0 | 0 | 0 | ' |
Various Cincinnati Bell Telephone notes [Member] | ' | ' | ' | ' | ' |
Debt Instruments [Abstract] | ' | ' | ' | ' | ' |
Cincinnati Bell Telephone Notes Outstanding | $134.50 | ' | $134.50 | ' | $134.50 |